1.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000430929, UVACC-HIC-11491, UVACC-34104, UVACC-MEL-44, UVACC-GCRC-CLS013, UVACC-HITC-02620, MDA-2005-0070, Mel 44, NCT00118274
|
|
2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000483131, UVACC-OVA-2, UVACC-HIC-10134, UVACC-PRC-236-02, OVA-2, NCT00373217
|
|
3.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000386176, UVACC-OVA3, UVACC-33204, UVACC-HIC-11276, NCT00091273
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 12 and over Sponsor: NCI, Other Protocol IDs: CDR0000430925, UVACC-MEL-45, UVACC-HIC-11490, UVACC-34204, NCT00118313
|
|
5.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 13498, R01CA057653, P30CA044579, UVACC-MEL-48, UVACC-IRB-13498, UVACC-PRC-450-07, Mel 48, NCT00705640
|